Cannabis and Medical Marijuana Segment

Facility Operations Related

Corporate and Eliminations

Consolidated

Three months ended September 30, 2018

Net revenue

$

101,407

$

930,214

$

-

$

1,031,621

Operating income (loss)

32,257

3,173

(238,527)

(203,097)

Interest income

18,850

1

22,727

41,578

Interest expense

-

4,713

(1,125)

3,588

Property additions

-

13,484

1,658

15,142

Depreciation and amortization

-

3,369

2,059

5,428

Three months ended September 30, 2017

Net revenue

$

5,040

$

810,062

$

-

$

815,102

Operating income (loss)

4,654

65,309

(256,944)

(186,981)

Interest income

71,219

1

22,688

93,908

Interest expense

-

4,567

(1,133)

3,434

Property additions

-

-

4,775

4,775

Depreciation and amortization

-

1,461

1,088

2,549

Nine months ended September 30, 2018

Net sales

$

598,539

$

2,680,541

$

-

$

3,279,080

Operating income (loss)

151,566

2,382

(761,932)

(607,984)

Interest income

62,759

2

61,403

124,164

Interest expense

181

14,704

(3,298)

11,587

Property additions

-

13,484

4,057

17,541

Total assets

4,270,527

1,150,657

2,736,576

8,157,760

Depreciation and amortization

-

8,554

5,530

14,084

Nine months ended September 30, 2017

Net sales

$

9,800

$

2,307,994

$

-

$

2,317,794

Operating income (loss)

8,729

140,257

(997,654)

(848,668)

Interest income

88,541

4

68,971

157,516

Interest expense

-

14,353

(3,402)

10,951

Property additions

-

-

7,909

7,909

Total assets

3,122,165

1,168,649

3,057,673

7,348,487

Depreciation and amortization

-

8,106

2,496

10,602